Our aim is to develop an internationally-renowned centre for translational cancer research and cancer education. This will be achieved by maximising the strategic opportunities available from combining high-class basic science and trials infrastructure with the largest clinical referral base in Europe.
Key components of our infrastructure include:
The Cancer Research UK Cancer Centre, which includes one of the largest Clinical Trials Units in the UK
The Henry Wellcome Building for Biomolecular Nuclear Magnetic Resonance Spectroscopy (HWB-NMR)
The Centre for Clinical Haematology (CCH)
The Birmingham Experimental Cancer Medicine Centre (ECMC)
The Wellcome Trust Clincal Research Facility (CRF)
Research Activity is focused in six major areas which span the natural history of cancer from cellular transformation through to development of evidence-based therapy:
Biomarkers, Proteomics & NMR
Cancer Cell Biology
Cancer Genetics and Epigenetics
Clinical Trials
Tumour Immunology and Immune/Gene Therapy
Viral Oncology
Main Cancer Sciences Building
HWB-NMR
Centre for Clinical Haematology